Logo image of LABP

LANDOS BIOPHARMA INC (LABP) Stock Analyst Earnings Estimates

NASDAQ:LABP - Nasdaq - US5150692011 - Common Stock - Currency: USD

22.93  +0.13 (+0.58%)

After market: 22.91 -0.02 (-0.09%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
LABP revenue by date.LABP revenue by date.
18M
-100.00%
EBITDA
YoY % growth
LABP ebitda by date.LABP ebitda by date.
-13.19M
-67.81%
-30.54M
-131.54%
-38.62M
-26.46%
-44.778M
-2.74%
-22.746M
42.72%
-33.66M
-48.11%
-45.084M
-33.94%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
LABP ebit by date.LABP ebit by date.
-13.29M
-67.38%
-30.68M
-130.85%
-38.82M
-26.53%
-43.478M
-3.71%
-22.593M
43.55%
-28.203M
-24.09%
-47.583M
-68.72%
-90.168M
-89.50%
-32.64M
63.80%
-32.64M-32.64M-32.64M
Operating Margin
LABP operating margin by date.LABP operating margin by date.
N/AN/A-215.67%N/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
LABP eps by date.LABP eps by date.
N/AN/AN/A
57.35%
-10.33
-8.56%
-3.49
64.69%
-2.23
35.44%
-1.72
23.06%
-1.21
29.38%
N/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth
-0.89
-41.67%
-0.82
13.19%
-0.44
55.70%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/AN/AN/A
EBIT
Q2Q % growth
-6.936M
-56.22%
-7.191M
-38.29%
-7.548M
-14.19%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth
-1.43
-58.89%
-1.02-0.41-40.20%
Q4 2023
Q2Q % growth
-0.99
23.85%
-0.93-0.06-6.08%
Q3 2023
Q2Q % growth
-0.94
53.00%
-0.90-0.04-4.13%
Q2 2023
Q2Q % growth
-0.63
77.50%
-1.120.4943.85%
Q1 2023
Q2Q % growth
-0.90
75.68%
-0.970.077.12%
Q4 2022
Q2Q % growth
-1.30
-282.36%
-1.940.6432.92%
Q3 2022
Q2Q % growth
-2.00
-525.00%
-2.890.8930.80%
Q2 2022
Q2Q % growth
-2.80
-2,433.33%
-3.720.9224.79%
Q1 2022
Q2Q % growth
-3.70
-873.68%
-3.54-0.16-4.64%
Q4 2021
Q2Q % growth

62.64%
-0.34%
Q3 2021
Q2Q % growth
-0.32 -0.450.1328.47%
Q2 2021
Q2Q % growth
0.12 -0.140.26184.03%
Q1 2021
Q2Q % growth
-0.38 -0.380.000.65%
Q4 2020
Q2Q % growth
-0.91 -0.70-0.21-29.93%
LABP Yearly EPS VS EstimatesLABP Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -5 -10 -15 -20
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2022
Q2Q % growth

-100.00%
%
LABP Yearly Revenue VS EstimatesLABP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 5M 10M 15M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 4.37% 0% 16.09%
RevenueN/A N/A N/A N/A